logo
搜索
菜单

的搜索结果

当前531/546页
排序: 总浏览数
16.8: Myocarditis IV: Nursing Management 01:22 min
16.8: Myocarditis IV: Nursing Management
12.11: Determination of Multiple Dosing Parameters: Loading and Maintenance Doses 01:25 min
12.11: Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
12.11: Determination of Multiple Dosing Parameters: Loading and Maintenance Doses 01:25 min
12.11: Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
13.3: Drug Dosing: Geriatric Patients 01:15 min
13.3: Drug Dosing: Geriatric Patients
6.21: Relationship with Parents: Attachment 01:28 min
6.21: Relationship with Parents: Attachment
6.5: Factors Influencing Attraction II: Physical Attraction 01:21 min
6.5: Factors Influencing Attraction II: Physical Attraction
6.15: Clearance Models: Noncompartmental Models 01:17 min
6.15: Clearance Models: Noncompartmental Models
3.3: Self-Esteem 01:28 min
3.3: Self-Esteem
10.9: Drug Product Stability 01:16 min
10.9: Drug Product Stability
17.7: Interpreting X̄ Charts 01:13 min
17.7: Interpreting X̄ Charts
13.20: Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance 01:25 min
13.20: Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
28.8: Elevation of Intermediate Points on Vertical Curves 01:20 min
28.8: Elevation of Intermediate Points on Vertical Curves
13.26: Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy 01:26 min
13.26: Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
10.5: In Vitro Drug Dissolution: Alternative Methods 01:17 min
10.5: In Vitro Drug Dissolution: Alternative Methods
7.20: Model Approaches for Pharmacokinetic Data: Physiological Models 01:15 min
7.20: Model Approaches for Pharmacokinetic Data: Physiological Models
6.7: Causes of Similarity-Dissimilarity Effect 01:26 min
6.7: Causes of Similarity-Dissimilarity Effect
17.2: Run Charts 01:12 min
17.2: Run Charts
13.18: Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment 01:08 min
13.18: Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
13.2: Drug Dosing: Obese Patients 01:21 min
13.2: Drug Dosing: Obese Patients
9.1: Accelerators 01:17 min
9.1: Accelerators
返回顶部